ProStrakan Group Signs Deal with Endo Pharmaceuticals (ENDP) for up to $210 Million
8/26/2009 7:13:08 AM
More...
|
ProStrakan Group And Orexo AB Announces That Abstral is Ready for Launch in France
6/30/2009 9:54:36 AM
More...
|
ProStrakan Group Announces Publication of Notice of Allowance for Sancuso US Patent
6/25/2009 11:32:07 AM
More...
|
ProStrakan Group Announces Change of CFO
6/3/2009 2:35:01 PM
More...
|
ProStrakan Group Release: Interim Management Statement
5/14/2009 1:19:38 PM
More...
|
ProStrakan Group Announces US Submission of Fortigel (testosterone) 2% Gel
5/5/2009 3:05:02 PM
More...
|
ProStrakan Group: Appointment of Joint Corporate Broker
4/1/2009 1:14:04 PM
More...
|
ProStrakan Group: Preliminary Results for the Year Ended 31 December 2008
3/18/2009 2:21:20 PM
More...
|
ProStrakan Group Announces Further Outlicensing Deals in Globalisation of Sancuso(R)
2/9/2009 1:02:31 PM
More...
|
ProStrakan Group and Paladin Labs Inc. (CC:PLB) Complete Agreement for Abstral(R) and Sancuso(R)
12/22/2008 9:15:49 AM
More...
|
|